£4.14
1.05% today
London, Oct 08, 12:45 pm CET
ISIN
GB00B082RF11
Symbol
RTO

Rentokil Initial Target price 2025 - Analyst rating & recommendation

Rentokil Initial Classifications & Recommendation:

Buy
52%
Hold
36%
Sell
12%

Rentokil Initial Price Target

Target Price £4.34
Price £4.10
Potential
Number of Estimates 17
17 Analysts have issued a price target Rentokil Initial 2026 . The average Rentokil Initial target price is £4.34. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 25 analysts: 13 Analysts recommend Rentokil Initial to buy, 9 to hold and 3 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Rentokil Initial stock has an average upside potential 2026 of . Most analysts recommend the Rentokil Initial stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Dec '24 2025
Estimates
Revenue Billion £ 7.41 6.15
1.13% 17.03%
EBITDA Margin 19.78% 20.18%
4.84% 2.04%
Net Margin 5.65% 9.16%
20.33% 62.19%

19 Analysts have issued a sales forecast Rentokil Initial 2025 . The average Rentokil Initial sales estimate is

£6.1b
Unlock
. This is
13.25% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
£7.6b 7.39%
Unlock
, the lowest is
£5.0b 29.29%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 £7.4b 1.13%
2025
£6.1b 17.03%
Unlock
2026
£6.3b 3.19%
Unlock
2027
£6.7b 5.01%
Unlock
2028
£8.5b 27.30%
Unlock
2029
£9.0b 6.18%
Unlock
2030
£8.8b 2.16%
Unlock
2031
£9.2b 4.95%
Unlock
2032
£9.7b 5.00%
Unlock

19 Analysts have issued an Rentokil Initial EBITDA forecast 2025. The average Rentokil Initial EBITDA estimate is

£1.2b
Unlock
. This is
8.64% lower
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
£1.6b 17.95%
Unlock
, the lowest is
£927m 31.74%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 £1.5b 3.76%
2025
£1.2b 15.34%
Unlock
2026
£1.3b 6.94%
Unlock
2027
£1.4b 7.54%
Unlock
2028
£1.9b 31.91%
Unlock
2029
£2.0b 8.56%
Unlock
2030
£1.6b 20.62%
Unlock
2031
£1.7b 6.97%
Unlock
2032
£1.9b 7.04%
Unlock

EBITDA Margin

2024 19.78% 4.84%
2025
20.18% 2.04%
Unlock
2026
20.91% 3.62%
Unlock
2027
21.41% 2.39%
Unlock
2028
22.19% 3.64%
Unlock
2029
22.69% 2.25%
Unlock

18 Rentokil Initial Analysts have issued a net profit forecast 2025. The average Rentokil Initial net profit estimate is

£563m
Unlock
. This is
65.96% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
£724m 113.32%
Unlock
, the lowest is
£371m 9.46%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 £418m 19.42%
2025
£563m 34.59%
Unlock
2026
£617m 9.55%
Unlock
2027
£685m 11.03%
Unlock

Net Margin

2024 5.65% 20.33%
2025
9.16% 62.19%
Unlock
2026
9.73% 6.22%
Unlock
2027
10.28% 5.65%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Dec '24 2025
Estimates
Earnings Per Share £ 0.17 0.22
19.05% 29.41%
P/E 18.39
EV/Sales 2.32

18 Analysts have issued a Rentokil Initial forecast for earnings per share. The average Rentokil Initial EPS is

£0.22
Unlock
. This is
83.33% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
£0.29 141.67%
Unlock
, the lowest is
£0.15 25.00%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 £0.17 19.05%
2025
£0.22 29.41%
Unlock
2026
£0.24 9.09%
Unlock
2027
£0.27 12.50%
Unlock

P/E ratio

Current 34.16 52.61%
2025
18.39 46.16%
Unlock
2026
16.79 8.70%
Unlock
2027
15.12 9.95%
Unlock

Based on analysts' sales estimates for 2025, the Rentokil Initial stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 2.01 12.23%
2025
2.32 15.38%
Unlock
2026
2.25 3.09%
Unlock
2027
2.14 4.77%
Unlock
2028
1.68 21.45%
Unlock
2029
1.58 5.82%
Unlock
2030
1.62 2.20%
Unlock
2031
1.54 4.72%
Unlock
2032
1.47 4.76%
Unlock

P/S ratio

Current 1.40 17.63%
2025
1.61 15.28%
Unlock
2026
1.56 3.09%
Unlock
2027
1.49 4.78%
Unlock
2028
1.17 21.45%
Unlock
2029
1.10 5.82%
Unlock
2030
1.13 2.21%
Unlock
2031
1.07 4.72%
Unlock
2032
1.02 4.76%
Unlock

Current Rentokil Initial Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Berenberg Bank
Locked
Locked
Locked Sep 29 2025
JP Morgan Cazenove
Locked
Locked
Locked Aug 11 2025
RBC Capital Markets
Locked
Locked
Locked Aug 01 2025
Deutsche
Locked
Locked
Locked Jul 21 2025
Deutsche
Locked
Locked
Locked Mar 07 2025
JP Morgan Cazenove
Locked
Locked
Locked Jan 14 2025
Deutsche
Locked
Locked
Locked Sep 12 2024
Analyst Rating Date
Locked
Berenberg Bank:
Locked
Locked
Sep 29 2025
Locked
JP Morgan Cazenove:
Locked
Locked
Aug 11 2025
Locked
RBC Capital Markets:
Locked
Locked
Aug 01 2025
Locked
Deutsche:
Locked
Locked
Jul 21 2025
Locked
Deutsche:
Locked
Locked
Mar 07 2025
Locked
JP Morgan Cazenove:
Locked
Locked
Jan 14 2025
Locked
Deutsche:
Locked
Locked
Sep 12 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today